Javascript must be enabled to continue!
Aging Effects on Epicardial Adipose Tissue
View through CrossRef
Epicardial fat is the visceral fat of the heart. Epicardial fat is a white adipose tissue, but it displays also brown-fat like or beige fat features. Under physiological conditions, epicardial fat has cardioprotective functions such as free fatty acids supply and thermoregulation of the adjacent myocardium. Epicardial adipose tissue encounters changes in the transition from embryological to childhood and then to adult life. Aging can affect the function and morphology of epicardial fat, more likely in women than in men. The effect of aging on the brown fat properties of the epicardial fat is the most prominent and with the greatest clinical implications. It is promising to know that epicardial fat responds to newer pharmaceutical drugs modulating the adipose tissue and potentially restoring its browning effects. Epicardial fat pro-inflammatory secretome is down-regulated in end-stage coronary artery disease. Chronic ischemia and adverse hemodynamic conditions can also affect the regulatory component of the epicardial fat. Epicardial fat may incur in apoptotic and fibrotic changes that alter its transcriptome and proteasome. In conclusion, aging and advanced stage of chronic diseases are likely to influence and affect epicardial fat genes and function
.
Whether the downregulation of the epicardial fat tissue is due more to aging than advancing stages of coronary artery disease, or more likely to the combination of both, would be object of future investigations.
Title: Aging Effects on Epicardial Adipose Tissue
Description:
Epicardial fat is the visceral fat of the heart.
Epicardial fat is a white adipose tissue, but it displays also brown-fat like or beige fat features.
Under physiological conditions, epicardial fat has cardioprotective functions such as free fatty acids supply and thermoregulation of the adjacent myocardium.
Epicardial adipose tissue encounters changes in the transition from embryological to childhood and then to adult life.
Aging can affect the function and morphology of epicardial fat, more likely in women than in men.
The effect of aging on the brown fat properties of the epicardial fat is the most prominent and with the greatest clinical implications.
It is promising to know that epicardial fat responds to newer pharmaceutical drugs modulating the adipose tissue and potentially restoring its browning effects.
Epicardial fat pro-inflammatory secretome is down-regulated in end-stage coronary artery disease.
Chronic ischemia and adverse hemodynamic conditions can also affect the regulatory component of the epicardial fat.
Epicardial fat may incur in apoptotic and fibrotic changes that alter its transcriptome and proteasome.
In conclusion, aging and advanced stage of chronic diseases are likely to influence and affect epicardial fat genes and function
.
Whether the downregulation of the epicardial fat tissue is due more to aging than advancing stages of coronary artery disease, or more likely to the combination of both, would be object of future investigations.
Related Results
ASSA13-02-23 Relationship of Thickness of Left Atrial Epicardial Adipose Tissue and Atrial Fibrillation
ASSA13-02-23 Relationship of Thickness of Left Atrial Epicardial Adipose Tissue and Atrial Fibrillation
Background
Obesity is an important risk factor for atrial fibrillation (AF). Epicardial adipose tissue in close anatomic proximity to cardiac structures and auton...
Association of epicardial adipose tissue thickness and left ventricular functions in children with primary dyslipidemia
Association of epicardial adipose tissue thickness and left ventricular functions in children with primary dyslipidemia
Abstract
Epicardial adipose tissue (EAT) is a component of visceral adiposity and mediates cardiac function and atherosclerosis via expressio...
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Exploring the Role of Visceral Fat as a Negative Regulator of Vascular Function In Obesity
Background and Objective. Obesity promotes endothelial dysfunction, a major contributor to the development of cardiovascular disease. Work from our lab and others previously showed...
Association of Region‐Specific Cardiac Adiposity With Dysglycemia and New‐Onset Diabetes
Association of Region‐Specific Cardiac Adiposity With Dysglycemia and New‐Onset Diabetes
Background
Visceral adipose tissue is assumed to be an important indicator for insulin resistance and diabetes beyond overweight/obesity. We hypothesized that region‐sp...
Echocardiographic association of epicardial fat with carotid intima–media thickness in patients with type 2 diabetes
Echocardiographic association of epicardial fat with carotid intima–media thickness in patients with type 2 diabetes
Background:
Epicardial fat is recognized as active endocrine organ and as emerging risk factor for cardio-metabolic diseases. The aim of this study was to explo...
227-OR: Disruption of Adipocyte YAP Improves Glucose Homeostasis in Mice and Decreases Adipose Tissue Fibrosis
227-OR: Disruption of Adipocyte YAP Improves Glucose Homeostasis in Mice and Decreases Adipose Tissue Fibrosis
Adipose tissue is a dynamic metabolic organ that is essential for the regulation of whole-body glucose homeostasis. Dysfunctional adipose tissue hypertrophy with obesity is associa...
1738-P: The Role of Adipocyte YAP in Glucose Homeostasis and Insulin Resistance In Vivo
1738-P: The Role of Adipocyte YAP in Glucose Homeostasis and Insulin Resistance In Vivo
Adipose tissue is a dynamic metabolic organ that is essential for the regulation of whole-body glucose homeostasis. Adipose tissue hypertrophy with obesity is associated with gluco...
Neuropathy and neural plasticity in the subcutaneous white adipose depot
Neuropathy and neural plasticity in the subcutaneous white adipose depot
Abstract
The difficulty in obtaining as well as maintaining weight loss, together with the loss of metabolic control in conditions like diabetes and cardiovascular ...

